Additionally, about half of the patients with GBM display poor treatment response to TMZ, possibly due to high expression of O6-methylguanine-DNA methyltransferase (MGMT), which lead to an overwhelming amount of recurrence in patients8. This evidence concerns the gene MGMT and glioblastoma.